MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Chiasma Company Profile (NASDAQ:CHMA)

Consensus Ratings for Chiasma (NASDAQ:CHMA) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $21.63 (680.69% upside)

Analysts' Ratings History for Chiasma (NASDAQ:CHMA)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016BarclaysDowngradeOverweight -> Equal Weight$40.00 -> $5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/18/2016OppenheimerReiterated RatingOutperform$43.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/18/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Chiasma (NASDAQ:CHMA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/29/2016        
5/11/2016Q1($0.63)($0.71)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q4($0.53)($0.61)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315($0.38)($0.46)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Chiasma (NASDAQ:CHMA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.70)($0.52)($0.61)
Q2 20162($0.78)($0.75)($0.77)
Q3 20162($0.88)($0.83)($0.86)
Q4 20162($0.93)($0.91)($0.92)
(Data provided by Zacks Investment Research)
Dividend History for Chiasma (NASDAQ:CHMA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Chiasma (NASDAQ:CHMA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/21/2015Health Ventures Lp 7-MedMajor ShareholderBuy93,750$16.00$1,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Chiasma (NASDAQ:CHMA)
DateHeadline
06/26/16 08:18 AMChiasma Incorporated (NASDAQ:CHMA) Shorts Decreased by 10.62% After Short Covering - Engelwood Daily
06/24/16 10:49 PMINVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Chiasma, Inc. and Reminds Investors with Losses to Contact the Firm - [Business Wire] - Khang & Khang LLP announces that a class action lawsuit has been filed against Chiasma, Inc. . Investors who purchased or otherwise acquired shares between July 15, 2015 and April 17, 2016, inclusive , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
06/24/16 08:00 PMINVESTOR ALERT: Investigation of Chiasma, Inc. Announced by the Law Firm Goldman Scarlato & Penny, P.C.; Investors Encouraged to Contact the Firm - [Business Wire] - Goldman Scarlato & Penny, P.C. announces an investigation on behalf of shareholders of Chiasma, Inc. concerning potential violations of the federal securities laws by the Company and company insiders.
06/24/16 05:27 PMAUGUST 8, 2016 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit Against Chiasma, Inc. And Reminds Investors With Losses To Contact The Firm - [Business Wire] - Lundin Law PC announces a class action lawsuit has been filed against Chiasma, Inc. concerning possible violations of federal securities laws between July 15, 2015 and April 17, 2016.
06/24/16 03:38 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Chiasma, Inc. of Class Action Lawsuit and Upcoming Deadline – CHMA - [GlobeNewswire] - NEW YORK, June 24, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Chiasma, Inc. and certain of its officers. The class action, filed in United States District Court, ...
06/24/16 03:19 PMSpirax Sarco evolves RIM10 to RIM20
06/24/16 10:50 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Chiasma, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 -- CHMA - [Marketwired] - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Chiasma, Inc. between July 15, 2015 and April 17, 2016. You ...
06/24/16 04:37 AMChiasma Inc (NASDAQ:CHMA) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 04:37 AMSHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces an Investigation of Chiasma, Inc. - CHMA - PR Newswire (press release)
06/23/16 05:35 PMSHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces an Investigation of Chiasma, Inc. - CHMA - [PR Newswire] - BALA CYNWYD, Pa., June 23, 2016 /PRNewswire/ -- Law Office of Brodsky & Smith, LLC announces an investigation of Chiasma, Inc. ("Chiasma" or the "Company") (Nasdaq -CHMA- News) for ...
06/23/16 10:36 AMNew Broker Ratings For Chiasma, Inc. (NASDAQ:CHMA) - FTSE News
06/22/16 08:30 PMChiasma, Inc. (NASDAQ:CHMA) Current Analyst Ratings - Fiscal Standard
06/21/16 04:30 PMSHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Chiasma, Inc. and Reminds Investors with Losses to Contact the Firm - [Business Wire] - Khang & Khang LLP announces that a class action lawsuit has been filed against Chiasma, Inc. . Investors who purchased or otherwise acquired shares between July 15, 2015 and April 17, 2016, inclusive , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
06/21/16 03:04 PMInvestor News: Lawsuit against Chiasma Inc (NASDAQ:CHMA) alleges Misleading Statements - GroundReport
06/21/16 07:56 AMInvestor News: Lawsuit against Chiasma Inc (NASDAQ:CHMA) alleges Misleading Statements
06/20/16 04:46 PMCHIASMA, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit - [Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of Chiasma, Inc.
06/20/16 10:46 AMSHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Lawsuit Involving Chiasma, Inc. and a Lead Plaintiff Deadline of August 8, 2016 -- CHMA - [GlobeNewswire] - NEW YORK, June 20, 2016-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Chiasma, ...
06/19/16 03:03 PMChiasma, Inc. (NASDAQ:CHMA) Analyst Price Targets For The Coming Week - Fiscal Standard
06/16/16 08:32 PMLundin Law PC Announces Investigation Of Chiasma, Inc. And Advises Investors With Losses to Contact the Firm
06/16/16 06:28 PMSHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of Chiasma, Inc. And Advises Investors With Losses to Contact the Firm - [Business Wire] - Lundin Law PC announces it is investigating claims against Chiasma, Inc. concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by Chiasma were false and misleading and/or failed to disclose material information regarding the Company’s financial performance.
06/16/16 04:19 PMSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Chiasma, Inc. -- CHMA - [GlobeNewswire] - WILMINGTON, Del., June 16, 2016-- Rigrodsky & Long, P.A.:. Do you, or did you, own shares of Chiasma, Inc.? Did you purchase your shares pursuant and/or traceable to the July 15, 2015 Registration Statement ...
06/15/16 03:36 PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Chiasma, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 – CHMA - [GlobeNewswire] - NEW YORK, June 15, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Chiasma, Inc. between July 15, ...
06/15/16 03:17 PMChiasma : Israeli drug developer Chiasma fires 33% of work force
06/15/16 12:00 PMChiasma, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors - [Business Wire] - Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court, District of Massachusetts against Chiasma, Inc.
06/15/16 10:30 AMSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Chiasma, Inc. (CHMA) and Lead Plaintiff Deadline - August 8, 2016 - [PR Newswire] - NEW YORK, June 15, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court, District of Massachusetts on behalf of those who purchased shares of Chiasma, Inc. ("Chiasma" or the "Company") (CHMA) between July 15, 2015 and April 17, 2016 inclusive (the "Class Period"). Chiasma is a biopharmaceutical company focused on developing and commercializing orphan medications to better meet the needs of patients and healthcare professionals. Chiasma's leading product is oral octreotide, Mycapssa, used to treat acromegaly, a condition resulting from excess growth hormone.
06/15/16 07:58 AMCHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race
06/15/16 07:58 AMIsraeli drug developer Chiasma fires 33% of work force
06/15/16 07:58 AMLawsuit for Investors in Chiasma Inc (NASDAQ:CHMA) over Alleged Misleading Statements Filed
06/14/16 03:07 PMLawsuit for Investors in Chiasma Inc (NASDAQ:CHMA) over Alleged Misleading Statements Filed - Digital Journal
06/14/16 08:19 AMChiasma Announces Corporate Restructuring Plan and Provides Regulatory Update Regarding Mycapssa™ - [at noodls] - WALTHAM, Mass., June 14, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced ...
06/14/16 08:16 AMChiasma to cut one-third of its workforce as part of restructuring -
06/14/16 08:07 AMCHIASMA, INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal -
06/13/16 08:10 PMIMPORTANT SHAREHOLDER NOTICE: Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Chiasma, Inc. To Contact Brower Piven Before The Lead Plai - [GlobeNewswire] - STEVENSON, Md., June 13, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...
06/13/16 10:10 AMScott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Chiasma, Inc. (NASDAQ: CHMA) Securities Case - [GlobeNewswire] - NEW YORK, June 13, 2016-- Scott+ Scott, Attorneys at Law, LLP, a global investor rights law firm, reminds investors that August 8, 2016 is the last day to file lead plaintiff papers in the securities lawsuit ...
06/10/16 09:11 PMGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Chiasma, Inc. (CHMA) - GlobeNewswire (press release)
06/10/16 08:00 PMGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Chiasma, Inc. (CHMA) - [GlobeNewswire] - NEW YORK, June 10, 2016-- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Chiasma, Inc. in the United States District Court for the District of Massachusetts on behalf ...
06/10/16 04:06 PMCHIASMA, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/10/16 04:00 PMChiasma, Inc. :CHMA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 -
06/10/16 12:40 PMThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Chiasma, Inc. Investors and Encourages Investors to Contact the Firm - [Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Chiasma, Inc. securities between July 15, 2015 and April 17, 2016, inclusive .
06/09/16 04:25 PMPomerantz Law Firm Announces the Filing of a Class Action against Chiasma, Inc. and Certain Officers – CHMA - [GlobeNewswire] - NEW YORK, June 09, 2016-- Pomerantz LLP announces that a class action lawsuit has been against Chiasma, Inc. and certain of its officers. The class action, filed in United States District Court, District ...
06/08/16 11:46 AMCHIASMA INC. (NASDAQ:CHMA) Financial Condition Compared to S&P 500 - CML News
06/03/16 09:17 PMStock Review and Earnings Check on Chiasma Inc (NASDAQ:CHMA) - HNN
06/01/16 11:46 AMTarget Price and Stock Performance Rundown for Chiasma Inc (NASDAQ:CHMA) - HNN - Target Price and Stock Performance Rundown for Chiasma Inc (NASDAQ:CHMA)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Chiasma Inc (NASDAQ:CHMA) shares ...and more »
05/31/16 08:54 PMChiasma to Present at Jefferies Global Healthcare Conference - GlobeNewswire (press release) - Chiasma to Present at Jefferies Global Healthcare ConferenceGlobeNewswire (press release)WALTHAM, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company developing an investigational new drug, Mycapssa™ (octreotide) capsules, for the potential maintenance therapy of adult patients with ...
05/31/16 03:13 PMChiasma (NASDAQ:CHMA) increased 2.65%: Petroleo Brasileiro Petrobras (NYSE:PBR), Elbit Imaging Ltd. (NASDAQ ... - KC Register - Chiasma (NASDAQ:CHMA) increased 2.65%: Petroleo Brasileiro Petrobras (NYSE:PBR), Elbit Imaging Ltd. (NASDAQ ...KC RegisterOn 12 May, Chiasma, Inc. (NASDAQ:CHMA) received a complete-response letter from the FDA on April 15 after it had publicly been talking for months about its plans to launch its drug, called Mycapssa. The drug is a once-a-day capsule intended to replace ...
05/31/16 07:22 AMChiasma to Present at Jefferies Global Healthcare Conference - [at noodls] - WALTHAM, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company developing an investigational new drug, Mycapssa™ (octreotide) capsules, for the potential maintenance ...
05/23/16 07:16 AMChiasma to Participate in AACE and ECE 2016 Conferences - [at noodls] - Publishes New Data Regarding Time-Weighted Average Response Rate from Initial Phase 3 Trial Presents New Injectable Somatostatin Analog Patient Reported Outcome Data Highlights Recently Initiated MPOWERED ...
05/22/16 01:02 PMNext Weeks Broker Price Targets For Chiasma, Inc. (NASDAQ:CHMA) - Share Trading News - Next Weeks Broker Price Targets For Chiasma, Inc. (NASDAQ:CHMA)Share Trading NewsChiasma, Inc. has a 50 day moving average of 5.54 and a 200 day moving average of 12.61. The stock's market capitalization is 69.50M, it has a 52-week low of 2.50 and a 52-week high of 30.52. The share price of the company (NASDAQ:CHMA) was up ...
05/21/16 01:41 PMShare Recap and Earnings Focus on Chiasma Inc (NASDAQ:CHMA) - Wall Street Hints and News - Share Recap and Earnings Focus on Chiasma Inc (NASDAQ:CHMA)Wall Street Hints and NewsPresently, covering analysts are anticipating Chiasma Inc (NASDAQ:CHMA) to report quarterly EPS of $-0.65. The company's next earnings report is expected to be released on or around 2016-08-10 for the period ending on 2016-06-30. The company posted ...and more »
05/21/16 01:41 PMRevenue Update on Chiasma Inc(NASDAQ:CHMA) - Trade Calls - Revenue Update on Chiasma Inc(NASDAQ:CHMA)Trade CallsChiasma Inc(NASDAQ:CHMA) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 11, 2016. Earnings per share were $-0.71. Analysts had estimated an EPS of $-0.63. In a different note, On Apr 25, ...
About Chiasma

Chiasma logoChiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial of its TPE platform-based product candidate, oral octreotide capsules (trade named as MYCAPSSA) for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Octreotide is an analog of somatostatin, a natural inhibitor of growth hormone secretion. The Company is developing octreotide capsules as a liquid-filled solid gelatin capsule formulation, which is intended to be taken over twice a day. The Company's TPE technology enhances the absorption through the intestinal wall of drugs. The Company also focuses on developing CH2 for Orphan indication.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CHMA
  • CUSIP:
Key Metrics:
  • Previous Close: $2.74
  • 50 Day Moving Average: $2.94
  • 200 Day Moving Average: $9.30
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $67.31M
  • Current Quarter EPS Consensus Estimate: $-2.81 EPS
Additional Links:
Chiasma (NASDAQ:CHMA) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha